LOCALIZATION OF A VITRONECTIN BINDING REGION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1

被引:0
|
作者
PADMANABHAN, J [1 ]
SANE, DC [1 ]
机构
[1] WAKE FOREST UNIV, BOWMAN GRAY SCH MED, DEPT INTERNAL MED, WINSTON SALEM, NC 27157 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The PAI-1 binding site for VN was studied using two independent methods. PAI-1 was cleaved by Staph V8 protease, producing 8 frag ments, only 2 of which bound to [I-125]-VN. These fragments were predicted to overlap between residues 91-130. Since PAI-2 has structural homology to PAI-1, but does not bind to vitronectin, chimeras of PAI-1 acid PAI-2 were constructed. Four chimeras, containing PAI-1 residues 1-70, 1-105, 1-114, and 1-167 were constructed and expressed in vitro. PAI-1, PAI-2, and all of the chimeras retained inhibitory activity for t-PA, but only the chimera containing PAI-1 residues 1-167 formed a complex with VN. Together, these results predict that the VN binding site of PAI-1 is between residues 115-130.
引用
收藏
页码:829 / 834
页数:6
相关论文
共 50 条
  • [41] GENETIC-VARIATION AT THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 LOCUS IS ASSOCIATED WITH ALTERED LEVELS OF PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY
    DAWSON, S
    HAMSTEN, A
    WIMAN, B
    HENNEY, A
    HUMPHRIES, S
    ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01): : 183 - 190
  • [42] MONOCLONAL-ANTIBODIES AGAINST A RECOMBINANT FORM OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 - EFFECTS ON TISSUE-PLASMINOGEN ACTIVATOR NEUTRALIZING AND VITRONECTIN BINDING-PROPERTIES
    REILLY, TM
    LORELLI, WF
    PIERCE, SK
    SPITZ, SM
    WALTON, HL
    FIBRINOLYSIS, 1993, 7 (06) : 373 - 378
  • [43] LOCALIZATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, PLASMINOGEN-ACTIVATOR INHIBITOR-1,2 AND PLASMINOGEN IN COLON-CANCER
    NAITOH, H
    EGUCHI, Y
    UEYAMA, H
    KODAMA, M
    HATTORI, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (01): : 48 - 56
  • [44] INTERACTION OF PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) WITH VITRONECTIN
    SALONEN, EM
    VAHERI, A
    POLLANEN, J
    STEPHENS, R
    ANDREASEN, P
    MAYER, M
    DANO, K
    GAILIT, J
    RUOSLAHTI, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (11) : 6339 - 6343
  • [45] IMMUNOHISTOCHEMICAL LOCALIZATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND INHIBITOR-2 IN EARLY HUMAN IMPLANTATION SITES
    HOFMANN, GE
    GLATSTEIN, I
    SCHATZ, F
    HELLER, D
    DELIGDISCH, L
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 170 (02) : 671 - 676
  • [46] ON THE REVERSIBLE INTERACTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND WITH UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    LIJNEN, HR
    VANHOEF, B
    COLLEN, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (07) : 4041 - 4044
  • [47] TGF-BETA INCREASES BOTH UROKINASE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1
    IWASA, M
    HASHIMOTO, K
    MATSUMOTO, K
    HIGASHIYAMA, M
    HASHIRO, M
    UEDA, K
    KIM, K
    NISHIDA, Y
    TAGO, H
    YOSHIKAWA, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 92 (03) : 451 - 451
  • [48] TGF-BETA INCREASES BOTH UROKINASE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1
    IWASA, M
    HASHIMOTO, K
    MATSUMOTO, K
    HIGASHIYAMA, M
    HASHIRO, M
    UEDA, K
    KIM, K
    NISHIDA, Y
    TAGO, H
    YOSHIKAWA, K
    CLINICAL RESEARCH, 1989, 37 (02): : A635 - A635
  • [49] BEHAVIOR OF TISSUE PLASMINOGEN-ACTIVATOR, PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND THEIR COMPLEX IN VARIOUS DISEASE STATES
    NIWANO, H
    TAKAHASHI, H
    TATEWAKI, W
    WADA, K
    SEKI, Y
    SHIBATA, A
    BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (04) : 389 - 393
  • [50] STRUCTURAL BASIS OF LATENCY IN PLASMINOGEN-ACTIVATOR INHIBITOR-1
    MOTTONEN, J
    STRAND, A
    SYMERSKY, J
    SWEET, RM
    DANLEY, DE
    GEOGHEGAN, KF
    GERARD, RD
    GOLDSMITH, EJ
    NATURE, 1992, 355 (6357) : 270 - 273